Researchers used a bioinformatics-plus-rat-model approach to investigate how palmatine may help treat T2DM-associated MASLD, ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today ...

Oral TYK2 inhibitor deucravacitinib receives FDA approval for active psoriatic arthritis based on significantly improved ...

After more than 15 years of setbacks, Mesoblast has finally secured its first FDA approval, and early signs suggest the ... Read More The post Dr Boreham’s Crucible: The long grind finally pays off ...

Explore cancer drug resistance and its significant impact on treatment options and patient outcomes in modern cancer therapy.

Resveratrol demonstrates the ability to restore mitochondrial integrity and preserve retinal thickness in diabetic models of ocular disease.

First approved treatment in Japan for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) Approval is based on positive Phase III data from multinational and Japanese studies in patients ...